Validation of Sysmex XT-2000iV generated quantitative bone marrow differential counts in untreated Wistar rats

Kay A Criswell1, Jeffrey H Bock, Samantha E Wildeboer

  • 1Pfizer Worldwide Research and Development, Drug Safety Research and Development, Groton, CT, USA.

Abstract

Related Concept Videos